GLUCOTROL

This brand name is authorized in Estonia, Hong Kong, Lithuania, Romania, Turkey, United States

Active ingredients

The drug GLUCOTROL contains one active pharmaceutical ingredient (API):

1 Glipizide UNII X7WDT95N5C - GLIPIZIDE

Glipizide is an oral blood-glucose-lowering drug of the sulfonylurea class. The primary mode of action of glipizide is the stimulation of insulin secretion from the beta-cells of pancreatic islet tissue. Read about Glipizide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GLUCOTROL XL Extended-release tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR
GLUCOTROL Tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BB07	Glipizide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1484412
Country: HK	Department of Health Drug Office	Identifier(s): 41847
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003801, 1003802
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65038001, W65039001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308031013, 8699532031006
Country: US	FDA, National Drug Code	Identifier(s): 0049-0170, 0049-0174, 0049-0178, 0049-4110, 0049-4120